CAO Pharmaceuticals

Early Stage

An Oral and Non-toxic Cancer Treatment Option

Analytics

Raised to Date: Raised: $5,000

Aggregate Commitments $

Platform

Silicon Prairie Online

Start Date

05/02/2022

Close Date

04/24/2023

Min. Goal

$10,000

Max. Goal

$5,000,000

Min. Investment

$1,000

Security Type

Equity - Common

Funding Type

RegCF

Series

Pre-Seed

Price Per Share

$1.00

Pre-Money Valuation

$1,000,000

Rolling Commitments $

Status

Active

Reporting Date

05/21/2022

Days Remaining

338

% of Min. Goal

50%

% of Max. Goal

0%

Likelihood of Max
unlikely
Avg. Daily Raise

$263

Momentum
cool.svg
Log in or create a free account today to gain access to KingsCrowd analytics.
Location

Webster, Texas

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B

Margin

Medium

Capital Intensity

High

Business Type

Growth

CAO Pharmaceuticals is testing the waters on Silicon Prairie Online. The pharmaceutical company specializes in oral and non-toxic cancer treatment options using camptothecin (cpt). The company is testing a cpt derivative, CZ48, for toxicity and efficiency against cancers of the bladder, breast, kidney, lungs, ovary, pancreas, and prostate. Zhisong Cao founded CAO Pharmaceuticals in May 2015. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $5,000,000. The campaign proceeds will be used for the Phase 2 FDA trial, trial expenses, laboratory rental, utilities, expenses, and pipeline medication development.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-186,265

$-604,397

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$54,884

$78,415

Accounts Receivable

$0

$0

Total Assets

$2,662,118

$2,693,828

Short-Term Debt

$2,433

$2,878

Long-Term Debt

$0

$0

Total Liabilities

$2,433

$2,878

Financials as of: 05/02/2022
Log in or create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Analyst Reports (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including KingsCrowd ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by KingsCrowd ratings
Company specific KingsCrowd rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
CAO Pharmaceuticals on Silicon Prairie Online 2022
$
Platform: Silicon Prairie Online
Security Type: Equity - Common
Valuation: $1,000,000

Follow company

Follow CAO Pharmaceuticals on Silicon Prairie Online 2022
View on Silicon Prairie Online
Bullish / Bearish
You're Bullish on CAO Pharmaceuticals on Silicon Prairie Online 2022

Thank you for your vote on CAO Pharmaceuticals on Silicon Prairie Online 2022

Bullish / Bearish
You're Bearish on CAO Pharmaceuticals on Silicon Prairie Online 2022

Thank you for your vote on CAO Pharmaceuticals on Silicon Prairie Online 2022